Application period is now closed.

The David Geffen School of Medicine (DGSOM) Research Themes, in collaboration with the Institute of Precision Health (IPH), offer the DGSOM Seed Grant Program in an effort to promote the assembly of teams of scientists that are well-positioned to perform innovative, high-impact research and ultimately compete for large team science grants from federal agencies and private foundations. 

How to Apply

Applications may include faculty throughout the UCLA campus in any biomedical or medical research area in which groundbreaking advances catalyzed by teams of researchers can be envisioned.

Visit the DGSOM Seed Grant Program page 
Complete information is available along with details on the most recent application cycle.


Past Seed Grant Awardees
View all previously funded projects and awardees
Contact Us
For questions regarding the content, eligibility or scope of this opportunity


The UCLA Clinical and Translational Science Institute (CTSI) is a research partnership of UCLA, Cedars-Sinai Medical Center, Charles R. Drew University of Medicine and Science and the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. Its mission is to bring biomedical innovations to bear on the greatest health needs of Los Angeles—one of the most ethnically and economically diverse counties in the United States. Our vision is to catalyze research that translates discoveries into tangible improvements in health care, disease prevention and health in our community. The UCLA CTSI is one of more than 50 research hubs supported by the Clinical and Translational Sciences Award (CTSA) program of National Center for Advancing Translational Sciences (NCATS). NCATS—one of 27 Institutes and Centers at the National Institutes of Health (NIH)—was established to transform the translational process so that new treatments and cures for disease can be delivered to patients faster.